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In this issue…Laura Erker and Markus Grompe provide the review
Signaling networks in hepatic oval cell activation. Oval
cells, also referred to as adult liver stem cells, proliferate
and differentiate during liver regeneration. This review
explores the factors involved in oval cell activation,
proliferation, migration, and differentiation.
In his piece On the road to reprogramming, Martin Pera
examines the contributions of some recent papers to the
rapidly advancing field of iPS cell biology. Included in this
analysis is the study published in this issue of Stem Cell
Research from Hideki Masaki and colleagues, Heterogeneity
of pluripotent marker gene expression in colonies gener-
ated in human iPS cell induction culture. Their study
identified a marked heterogeneity in morphology and gene
expression amongst colonies generated by a four-gene
(Oct3/4, Sox2, c-Myc, and Klf4) transduction protocol in
human neonatal skin-derived cells. As Martin Pera commen-
ted, there was clear evidence for partial reprogramming in
many colonies, with only a small minority of colonies
displaying an ES cell-like morphology and expressing all
eight pluripotency-associated genes examined (chosen on
the basis of their consistent expression in human ES cells).
Importantly, even colonies retaining a fibroblast-like mor-
phology expressed nanog, TDGF1, and DNMT3b, indicating
that the expression of these core pluripotency genes was
insufficient to guarantee complete reprogramming. The iPS
cell lines that Masaki et al. derived in this study maintained a
diploid karyotype, and genome-wide SNP analysis did not
reveal any submicroscopic genetic changes in the repro-
grammed lines. Pera comments further that these findings
provide convincing evidence that genetic alteration is not
required for establishment or progressive growth of human
iPS cell lines, even in chemically defined media.
The molecular mechanisms controlling DNA-damage-
induced apoptosis of human embryonic stem cells (hESC)
are poorly understood. The article by Catarina Grandela and
colleagues, p53 is required for etoposide-induced apopto-
sis of human embryonic stem cells, explores the mechan-
isms for etoposide induced apoptosis of hESCs. Their study
demonstrates that p53 is required for etoposide-induced
apoptosis of hESC and that undifferentiated hESC that
express Oct4 are much more sensitive to etoposide-induced
apoptosis than their more differentiated progeny.1873-5061/$ – see front matter © 2008 Published by Elsevier B.V.
doi:10.1016/j.scr.2008.05.001Hematopoietic cells have been demonstrated to
survive in many nonhematopoietic tissues after transplan-
tation. Apparent “bone-marrow-derived” cerebellar Pur-
kinje cells in fact result from fusion events and it has
been suggested that fusion may be a natural physiological
phenomenon to rescue dysfunctioning cells. In their
article Cerebellar heterokaryon formation increases
with age and after irradiation, Anita Wiersema and
colleagues show that fusion of transplanted bone marrow
cells with resident Purkinje cells is age-dependent and is
strongly enhanced when Purkinje cells are damaged by
high-dose irradiation.
In their thought-provoking article Reduction of myocar-
dial infarct size by human mesenchymal stem cell
conditioned medium, Leo Timmers and colleagues demon-
strate cardioprotection in a porcine model of ischemia and
reperfusion injury by intravenous and intracoronary admin-
istration of human MSC secretions. Human MSC-conditioned
medium (CM) treatment was associated with a 60% reduction
in infarct size and marked improvement of systolic and
diastolic cardiac performance. Fractionation studies
revealed that the responsible paracrine factor of human
MSCs is likely to be a large complex rather than a single small
molecule. This study identifies human MSC-CM as a promising
therapeutic option for reducing myocardial infarct size in
patients with acute MI and suggests a broader therapeutic
potential for stem cell secretions.
Still on a cardiac theme, Marie-José Goumans and
colleagues describe the efficient isolation and propagation
of human cardiomyocyte progenitor cells (hCMPCs) from
fetal heart and patient biopsies in their paper TGF-β1
induces efficient differentiation of human cardiomyocyte
progenitor cells into functional cardiomyocytes in vitro.
The hCMPC cultures they established from over 70% of adult
atrial biopsies differentiated into spontaneously beating
myocytes following addition of transforming growth factor β.
These are the first cells isolated from human heart that
proliferate and form functional cardiomyocytes without
requiring co-culture with neonatal myocytes.Andrew Elefanty
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